These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Naftidrofuryl can enhance the quality of life in patients with intermittent claudication. Spengel F, Brown TM, Poth J, Lehert P. Vasa; 1999 Aug 12; 28(3):207-12. PubMed ID: 10483329 [Abstract] [Full Text] [Related]
17. Padma 28 for intermittent claudication. Morling JR, Maxwell H, Stewart M. Cochrane Database Syst Rev; 2013 Jul 16; (7):CD007371. PubMed ID: 23861015 [Abstract] [Full Text] [Related]
18. Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis. Girolami B, Bernardi E, Prins MH, Ten Cate JW, Hettiarachchi R, Prandoni P, Girolami A, Büller HR. Arch Intern Med; 1999 Feb 22; 159(4):337-45. PubMed ID: 10030306 [Abstract] [Full Text] [Related]
19. Pentoxifylline for intermittent claudication. Salhiyyah K, Forster R, Senanayake E, Abdel-Hadi M, Booth A, Michaels JA. Cochrane Database Syst Rev; 2015 Sep 29; 9(9):CD005262. PubMed ID: 26417854 [Abstract] [Full Text] [Related]
20. The limits of evidence in drug approval and availability: a case study of cilostazol and naftidrofuryl for the treatment of intermittent claudication. Hong H, Mackey WC. Clin Ther; 2014 Aug 01; 36(8):1290-301. PubMed ID: 25012728 [Abstract] [Full Text] [Related] Page: [Next] [New Search]